Drug Trial Radar · NCT04803422
Per Oral Versus Intravenous Postoperative Antibiotics After Surgery for Complicated Appendicitis.
Last checked: Nov 19, 2026Latest source record: Oct 1, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,193
Actual
Start
Apr 1, 2021
Primary completion
May 31, 2024
Study completion Jun 30, 2024
Sponsor
- Lead sponsor
- Zealand University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 17, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The PIPA trial is a prospective, multicentre, cluster randomized cluster crossover non-inferiority study. We aim to test whether a three-day postoperative course of per oral antibiotics is non-inferior to a three-day postoperative course of intravenous antibiotics as standard care after laparoscopic surgery for complicated appendicitis in regards to the risk of postoperative intraabdominal abscess formation within 30-days
Conditions
- Complicated Appendicitis
Interventions
AntibioticDrug
The study aims to test whether oral antibiotics is non-inferior compared to intravenous antibiotics.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Intra-abdominal abscessTime frame: Assessed at postoperative day 30
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Slagelse Hospital, Department of Surgery
Slagelse, Denmark
Department of Surgery, Slagelse Hospital
Slagelse, Denmark
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.